University of Kentucky

UKnowledge
Chemistry Faculty Patents

Chemistry

1-23-2007

Catalytic Cleavage of Phosphate Ester Bonds by Boron Chelates
David A. Atwood
University of Kentucky, datwood@uky.edu

Follow this and additional works at: https://uknowledge.uky.edu/chemistry_patents
Part of the Chemistry Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Recommended Citation
Atwood, David A., "Catalytic Cleavage of Phosphate Ester Bonds by Boron Chelates" (2007). Chemistry
Faculty Patents. 14.
https://uknowledge.uky.edu/chemistry_patents/14

This Patent is brought to you for free and open access by the Chemistry at UKnowledge. It has been accepted for
inclusion in Chemistry Faculty Patents by an authorized administrator of UKnowledge. For more information, please
contact UKnowledge@lsv.uky.edu.

US007166591B1

(12) United States Patent
Atwood
(54)

US 7,166,591 B1
Jan. 23, 2007

CATALYTIC CLEAVAGE OF PHOSPHATE

(p-nitrophenyl) phosphate. Inorg. Chem. 1998. vol. 37. pp. 6832

ESTER BONDS BY BORON CHELATES

6838.

(75) Inventor:

David Allan Atwood, Lexington, KY

(Us)

Notice:

Subject to any disclaimer, the term of this
patent is extended or adjusted under 35

U.S.C. 154(b) by 0 days.

(21) App1.No.: 10/774,619
(22) Filed:

Feb. 9, 2004
Related US. Application Data

(60)

Provisional application No. 60/445,985, ?led on Feb.
7, 2003.

(51)

Int. Cl.
A61K 31/555

(52)
(58)

US. Cl. ........................ .. 514/2305; 544/69; 549/4
Field of Classi?cation Search ................ .. 544/69;

(2006.01)

514/2305; 549/4
See application ?le for complete search history.
(56)

Kaminskaia et al. Reactivity of u-hydroxodiZinc (11) centers in
enzymatic catalysis through model studies. Inorg. Chem. vol. 39.
2000. pp. 3365-3373.

(73) Assignee: University of Kentucky Research
Foundation, Lexington, KY (US)
(*)

(10) Patent N0.:
(45) Date of Patent:

References Cited
OTHER PUBLICATIONS

Chapman et al. Selective hydrolysis of phosphate esters, nitrophenyl
phosphates and UpU, by dimetric Zinc complexes depends on the
spacer length. J. Ame. Chem. Soc. 1995. vol. 117. pp. 5462-5469.

Molenveld et a1. Highly e?‘icient phosphate diester transesteri?ca
tion by a Calix [4] arene-based dinuclear Zinc (II) catalyst. J. Am.
Chem. Soc. vol. 119. 1997. pp. 2948-2949.
Benton et al. The cleavage of ethers with boron bromide. I. Some
common ether. J. Am/ Chem. Soc. vol. 64. 1942. pp. 1128-1129.

Kim et al. Direct conversion of silyl ethers into alkyl bromides with
boron tribrornide. J. Org. Chem. vol. 53. 1988. pp. 3111-3113.

BaZZicalupi et al. Carboxy and diphosphate ester hydrolysis by a
diZinc complex with a new alcohol-pendant macrocycle. Inorg.
Chem. 1999. vol. 38. pp. 4115-4122.
Ember Lois. EPA Destroying chemical armszNo easy task. C & EN.

Aug. 30, 1999. pp. 11-12.
Ranu et a1. Dealkylation of ethers. A review. Organic preparations
and procedures int. vol. 28. No. 4. pp. 371-409.

Miguel-Angel Munoz-Hernandez et al., “Reactivity and DerivitiZa
tion of Five-Coordinate, Chelated Aluminum,” Inorg. Chem, 2001,
40, 6782-6787.
Y. Wang et al., “Ligand-Tetrahydrofuran Coupling in Chelated
Aluminum Phosphinates,” Inorg. Chem. 2002, 41, 558-565.
YuZhong Wang et al., “Five-Coordinate Organoaluminum
Acetylides and Crystal Structure of the Hydrosylate, [Salophen
(tBu)Al]20,” Journal of Organometallic Chemistry 689 (2004).

KeiZer et al., Canadian J. Chem, (2002), vol. 80, No. 11, p.

759-765.

1463-68.*

David, Michael D. et al., Accelerated hydrolysis of industrial
organophosphates in water and soil using sodium perborate;
Environ. Pollution 105 (1999) 121-128.
Olivanen, Mikko et al., Kinetics and Mechanisms for the Cleavage
and IsomeriZation of the Phosphodiester Bonds of RNA by Bronsted
Acids and Bases; Chem. Rev. 1998, 98, 961-990.
Blasko, Andrei eta1., Recent Studies of Nucleophilic, General-Acid,
and Metal Ion Catalysis of Phosphate Diester Hydrolysis; Acc.
Chem. Res. 1999, 32, 475-484.

David et al. Accelerated hydrolysis of industrial organophosphates
in water and soil using sodium perborate. Environmental Pollution.
vol. 105. 1999. pp. 121-128.

Wei et al. Chelated Borates: Synthesis, reactivity, and cation for
mation. Inorg. Chem. vol. 37. 1998. pp. 4934-4938.
Wei et al. Synthesis and Structures of Salon-Supported Borates
Containing Siloxides. Inorg. Chem. vol. 38. 1999. pp. 3914-3918.
Brown et al. An intramolecularly Stabilized Arylboron Dibromide.
Heteroatom Chemistry. vol. 9. No. 1. 1998. pp. 79-83.
Yang et al. Chemical detoxi?cation of Nerve Agent VX. Acc. Chem.

(Continued)

Res. vol. 32. 1999. pp. 109-115.

Blasko et al. Recent Studies of Nucleophilic General-Acid, and

Metal Ion Catalysis of Phosphate Diester Hydrolysis. Acc. Chem.
res. vol. 32. 1999. pp. 475-484.

Oivanen et al. Kinetics and Mechanisms for the cleavage and
IsomeriZation of the Phosphodiester bonds of RNA by bronsted

Primary ExamineriTao?q Solola
(74) Attorney, Agent, or FirmiKing & Schickli, PLLC

(57)

ABSTRACT

acids and Bases. Chem. Rev. vol. 87. 1998. pp. 961-990.

Gajda et al. Highly ellicient phosphodiester hydrolysis promoted by
dinuclear copper (II) complex. Inorg. Chem. vol. 40. 2001. pp.
4918-4927.

Jones et al. Enhanced base hydrolysis of coordinated phosphate
esters: the reactivity of an unusual cobalt (III) amine dimer. J. Am.
Chem. Soc. 1984. vol. 106. pp. 7807-7819.
Vance et al. Functional group convergency in a binuclear

dephosphorylation reagent. J. Ame. Chem. Soc. vol. 115. 1993. pp.
12165-12166.

McCue et al. Hydrolysis of a model for the 5‘-cap pf mRNA by

dinuclear copper (II) and Zinc (II) Complexes. Rapid hydrolysis by

Novel chemical compounds are disclosed having the general
formula L{YXm}n, wherein X is selected from the Group 13
elements, Y is a halide, and L is a chelating ligand containing
at least one binding atom contacting the Group 13 element,
the atom being selected from the group consisting of C, N,
O, and S, and m and n are integers having a value of at least
1. L may be a SchiiT base type ligand, such as a salen ligand.

The compositions of the present invention may be bidentate,
quadridentate, or greater. The compositions may be used in
dealkylation of phosphate esters or ethers. Advantageously,

four copper (11) ions. Inorg. Chem. vol. 38. 1999. pp. 6136-6142.
Scrimin et al. Comparative reactivities of phosphate ester cleavages
by metallomicelles. Langmuir. vol. 12. 1996. pp. 6235-6241.
Yamami et al. Macrocyclic heterodinuclear ZnIIPbII complexes:

the methods of the present invention may be rendered

synthesis, structures, and hydrolytic function toward Tris

12 Claims, 5 Drawing Sheets

catalytic.

US 7,166,591 B1
Page 2
OTHER PUBLICATIONS

plexes Depends on the Spacer Length; J. Am. Chem. Soc. 1995, 117,

BaZZicalupi, Carla et al., Carboxy and Diphosphate Ester

Molenveld, Peter et al., Highly E?icient Phosphate Diester
Transesteri?cation by a Calix[4]arene-Based Dinuclear Zinc(II)
Catalyst;J. Am. Chem. Soc. 1997, 119, 2948-2949.
Benton, F.L. et al., The Cleavage of Ethers With Boron Bromide;

5462-5469.

Hydrolysis by a DiZinc Complex With a New Alcohol-Pendant

Macrocycle; Inorg. Chem. 1999, 38, 4115-4122.
Gajda, Tamas et al., Highly Ef?cient Phosphodiester Hydrolysis
Promoted by a Dinuclear Copper (II) Complex; Inorg. Chem., 2001,
40, 4918-4927.
Jones, David R. et al., Enhanced Base Hydrolysis of Coordinated
Phosphate Esters: The Reactivity of an Unusual Cobalt (III) Amine
Dimer; J. Am. Chem. Soc. 1984, 106, 7807-7819.
Vance, David H. et al., Functional Group Convergency in a
Binuclear Dephosphorylation Reagent; J. Am. Chem. Soc., 1993,
115, 12165-12166.
McCue, Kevin P. et al., Hydrolysis of a Model for the 5‘-Cap of
mRNA by Dinuclear Copper (II) and Zinc (II) Complexes . . . Rapid

Contrib. from Chemical Labs of U. of Notre Dame, May 1942; vol.
64 p. 1128.

Kim, Sunggak et al., Direct Conversion of Silyl Ethers into Alkyl
Bromides With Boron Tribromide, J. Org. Chem. 1988, 53, 3111
3 113.

Wei, Pingrong et al., Synthesis and Structure of Salen-Supported
Borates Containing Siloxides, Inorg. Chem. 1999, 38, 3914-3918.
Brown, David S., An Intramolecularly Stabilized Arylboron

Tris(p-nitrophenyl) Phosphate; Inorg. Chem. 1998, 37, 6832-6838.

Dibromide, Heteroatom Chem. vol. 9, No. 1, 1998, 79-83.
Yang, Yu-Chu, Chemical Detoxi?cation of Nerve Agent VX, Acc.
Chem. Res. 1999, 32, 109-115.
Ember, Lois, Destroying chemical arms: No easy task, C&EN Aug.
30, 1999, 11.
Hileman, bette, EPA Cuts Use of Common Pesticide, C&EN Jun.
12, 2000, 11.
Goodman, Steven N. et al., A Practical Synthesis of a,B-Unsaturated
Imides, Useful Substrates For Asymmetric Conjugate Addition
Reactions, Adv. Synth. Catal. 2002, 344, No. 9.

Chapman, William H. Jr. et al., Selective Hydrolysis of Phosphate
Esters, Nitrophenyl Phosphates and UpU, by Dimeric Zinc Com

* cited by examiner

Hydrolysis by Four Copper (II) Ions; Inorg. Chem. 1999, 38,
6136-6142.

Scrimin, Paolo et al., Comparative Reactivities of Phosphate Ester

Cleavages by Metallomicelles, Langmuir 1996, 12, 6235-6241.
Kaminskaia, Natalia V., et al., Reactivity of u-HydroxodiZinc (II)
Centers in Enzymatic Catalysts through Model Studies; Inorg.
Chem. 2000, 39, 3365-3373.
Yamami, Masako et al., Macrocyclic Heterodinuclear ZnIIPbII
Complexes: Synthesis, Structures and Hydrolytic Function toward

U.S. Patent

Jan. 23, 2007

Sheet 1 0f 5

US 7,166,591 B1

FIG. 1

m

mU

0mm
X

\B/
U

1

mU

\/\ /\/
XN

N

\
/\
B

U.S. Patent

Jan. 23, 2007

Sheet 2 0f 5

FIG. 2

US 7,166,591 B1

U.S. Patent

Jan. 23, 2007

Sheet 3 0f 5

US 7,166,591 B1

+5I2O

29m :
6b~m

c
55

3@m£25 : 945205S,“:.25

3.52%

U.S. Patent

Jan. 23, 2007

Sheet 4 0f 5

US 7,166,591 B1

251:
6amv

N2 0%

$
9
3
5
1
8
k
?
m
o
i
?
g=.|
am-t=EmN?d

U.S. Patent

Jan. 23, 2007

Sheet 5 0f 5

mUH“

US 7,166,591 B1

920%
N

\mml

imp

O
/
\

GAu

(x?a

O

w

um5H5=
/

US 7,166,591 B1
1

2

CATALYTIC CLEAVAGE OF PHOSPHATE
ESTER BONDS BY BORON CHELATES

undergo unWanted side effects upon reaction With the nerve

This application claims the bene?t of US. Provisional
Patent Application Ser. No. 60/445,985 ?led Feb. 7, 2003.
This invention Was made With partial Government support

SUMMARY OF THE INVENTION

agents, and Will be substantially non-toxic.

In accordance With the foregoing, a neW class of chelating
ligands have been synthesiZed Which serve as catalysts for
the dealkylation of phosphate ester and ether bonds. Each
ligand comprises a Group 13 element and a halide. While not
Wishing to be bound by any theory, When combined With a

under NSF CAREER aWard CHE 9816155. The Govem
ment may have certain rights in this invention.
TECHNICAL FIELD

molecule containing a phosphate ester bond or an ether

bond, it is believed that the ligand undergoes dissociation of

The present invention relates to compositions and meth
ods for cleavage of phosphate ester and ether bonds. In
particular, the invention relates to a chelating ligand com
prising a Group 13 element and a halide, and to methods for
using the ligand for dealkylation of a phosphate ester or an
ether.
BACKGROUND OF THE INVENTION

a halide Which then attacks a carbon atom of the bond being

broken, thereby cleaving the bond.
In one aspect of the invention a chemical compound is

provided, comprising the general formula L{YXm}n. Y may

20

It is knoWn that the breaking of a phosphate ester bond is
an important step in the destruction of chemical Warfare
agents such as Sarin gas and VX, in the destruction of

pesticides such as chloropyrifos, and in other biological
systems. Such compounds irreversibly block a serine
hydroxy group in the cellular enZyme acetylcholinesterase

Group 13 element, the atom selected from the group con

sisting of C, N, O, and S, and m and n are integers having
a value of at least 1.
25

rium, and X may be selected from the halide group consist

ing of ?uorine, chlorine, bromine, iodine, and astatine. In
30

one embodiment, L may be a salen ligand Which is bidentate,
quadridentate, or greater. Typically, L is selected from the

group consisting of Salen (tBu), Salpen (tBu), Salben (tBu),

targeted as a method of decontamination. Many such meth
ods use d-block metals such as cobalt, copper, and Zinc. It is

also knoWn to destroy nerve agents by hydrolyZing them

In another aspect, L may be a Schilf base-containing
ligand. Y may be selected from the Group 13 elements

consisting of boron, aluminum, gallium, indium, and tellu

by phosphorylation, thereby disrupting the cells’ neurologi
cal function. Accordingly, substantial effort has been
devoted to development of methods for decontamination of
such nerve agents and pesticides. The cleavage of the
PA)*C bond in such nerve agents/pesticides has been

be selected from the Group 13 elements consisting of boron,
aluminum, gallium, indium, and tellurium. X may be
selected from the halide group consisting of ?uorine, chlo
rine, bromine, iodine, and astatine. L is typically a chelating
ligand containing at least one binding atom contacting the

and Salhen (tBu). The general formula of the chemical
compound may be:
35

using basic solutions and/or bleach to oxidiZe them to less

toxic inorganic phosphates and alkali. HoWever, these solu
tions are caustic and should only be handled under carefully
controlled conditions. Large excesses of bleach and/or bases
are required for successful decontamination, and the active

40

agent (chlorine) in bleach decreases With time. Further,
bases and bleach are not selective for nerve agents, and

readily undergo undesirable and potentially explosive side
reactions.
Similarly, methods are knoWn for breaking the CiO4C

45

bond in ethers such as methyl tertiary butyl ether (MTBE) to

prevent, for example, contamination of groundWater
thereby. Prior art methods include cleavage by hydrogen

halides, organic acids, amines/amine salts, sulfonyl halides,
inorganic acid anhydrides, LeWis acid halides, Grignard

50

reagents, and alkali metal alkyls. The modes of action of
these reagents are varied, including elimination, substitu
tion, and oxidative cleavage. Further, it is knoWn to cleave
MTBE by concentrated acid. HoWever, concentrated acid
also risks contamination of the environment, and the rate of
hydrolysis is sloW When dilute aqueous acid is used to avoid
contamination. Biodegradation of MTBE is sloW under
anaerobic and aerobic conditions using conventional meth
odology, and certain methods such as gas phase catalytic

55

oxidation of MTBE require high temperatures.

60

In yet another aspect, a method is provided for dealkyla
tion of a phosphate ester or an ether, comprising contacting
the phosphate ester or ether With a compound comprising the

successful deactivating/destroying agent for such toxic
nerve agents as nerve gas (Sarin gas, VX, and the like) and

organophosphate pesticides. Such an agent should be easily
synthesiZed from inexpensive reagents, should be soluble in
the same solvents as the nerve gases/pesticides, Will pref

erably be selective for the nerve agents, Will not readily

general formula L{YXm}n as described above. As described,
L is typically a salen ligand, Y is typically boron or alumi
num, and X is typically chlorine, bromine, or iodine.
In still yet another aspect of the present invention, a

There is accordingly identi?ed a need in the art for a

catalytic method for dealkylation of a phosphate ester or an
65

ether, comprising contacting the phosphate ester or ether
With the compositions as described above in the presence of
BBr3. The phosphate ester or ether and BBr3 may be added

US 7,166,591 B1
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in equimolar amounts. Typically, the dealkylation reaction
using the compositions and methods of the present invention
is conducted at ambient temperature. Addition of an excess

FIG. 5 schematically depicts the formation of a cationic
intermediate from a composition of the present invention.
Reference Will noW be made in detail to the presently

of BBr3 renders the reaction catalytic, allowing regeneration

preferred embodiments of the invention, examples of Which

of the original composition and continuation of the reaction.
Yet still further, the present invention provides a catalytic

are illustrated in the accompanying draWings.

method for dealkylation of a phosphate ester or an ether,
comprising contacting the phosphate ester or ether With a

DETAILED DESCRIPTION OF THE
INVENTION

compound comprising the general formula L{YXm}n
WhereinY is selected from the Group 13 elements consisting

In accordance With one aspect of the present invention,
the composition provided by the present invention may be a
chelate having the general formula L{YXm}n, Where Y is a
Group 13 element, X is a halide, and L is chelating ligand
having a bidentate binding site comprising sites E and E'
contacting the Group 13 element. E and E' may be O, N, P,
S, or any combination thereof. Both bidentate (FIG. 1),

of boron, aluminum, gallium, indium, and tellurium, X is
selected from the halide group consisting of ?uorine, chlo

rine, bromine, iodine, and astatine, L is a chelating ligand
containing at least tWo molecules E and E' contacting the
Group 13 element, the molecules E and E' being selected
from the group consisting of C, N, O, and S, and m and n are
integers having a value of at least 1. Typically, the compound
generates a cationic intermediate upon contacting the phos
phate ester or ether, the cationic intermediate having the

general formula:

quadridentate (FIG. 2), and greater ligands are contemplated
by the present invention. The compositions of the present
invention shoW excellent activity in dealkylating various
20

phosphates and ethers as Will be shoWn herein. An additional
advantage is that the method of the present invention may be
conducted at room temperature.

In one embodiment, the present invention provides a

chemical compound comprising a chelating ligand L Which
25

As describing above, L may be a Schilf base-containing
ligand, such as a salen ligand. L may be a bidentate ligand,
a quadridentate ligand, or greater. In one embodiment, L is

selected from the group consisting of Salen (tBu), Salpen
(tBu), Salben (tBu), and Salhen (tBu). The reaction is ren
dering catalytic by conducting it in the presence of BBr3.
The phosphate ester or ether and BBr3 may be added in
equimolar amounts. The dealkylation reaction may be con
ducted at ambient temperature.
Other objects of the present invention Will become appar
ent to those skilled in this art from the folloWing description
Wherein there is shoWn and described a preferred embodi

is a salen ligand, Which may have the general formula:

30

35

40

ment of this invention, simply by Way of illustration of the
modes currently best suited to carry out the invention. As it

Will be realiZed, the invention is capable of other different
embodiments and its several details are capable of modi?

cation in various, obvious aspects all Without departing from

45

the invention. Accordingly, the draWings and descriptions
Will be regarded as illustrative in nature and not as restric

tive.

As discussed previously, Y may be selected from the Group
BRIEF DESCRIPTION OF THE DRAWING

50

13 elements consisting of boron, aluminum, gallium,

The accompanying draWings incorporated in and forming

indium, tellurium, and any combination thereof. X may be
selected from the halide group consisting of ?uorine, chlo

a part of the speci?cation illustrates several aspects of the

rine, bromine, iodine, astatine, and any combination thereof.

present invention and, together With the description, serves
to explain the principles of the invention. In the draWing:

55

a value of at least 1.

FIG. 1 is a structural depiction of a bidentate ligand

according to the present invention, Wherein X is a halide;
FIG. 2 is a structural depiction of a quadridentate ligand
according to the present invention, Wherein X is a halide and
L is a quadridentate Schilf base ligand;
FIG. 3 schematically depicts preparation of a bidentate

60

Other aspects of the present invention Will become appar
ent to those skilled in this art from the folloWing description
Wherein there is shoWn and described a preferred embodi
ment of this invention, simply by Way of illustration of one
of the modes best suited to carry out the invention. As it Will
be realiZed, this invention is capable of other different
embodiments and its several details are capable of modi?

65

cation in various, obvious aspects all Without departing from
the intended scope of the invention. Accordingly, the
descriptions and examples herein Will be regarded as illus

ligand according to the present invention by combining

Salpen(zBu)[B(OMe)2]2 (l) and Salben(tBu)[B(OMe)2]2 (2)
With a stoichiometric amount of BBr3;

FIG. 4 graphically shoWs a catalytic process for dealky
lation of a phosphate ester according to the present inven

tion; and

E and E' may be selected from the group consisting of C, N,
O, S, and any combination thereof, and n is an integer having

trative in nature and not as restrictive.
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EXAMPLE 1

1H NMR. As shoWn in Table 1, signi?cant dealkylation,
measured by the amount of phosphate remaining in the

Preparation of Salpen("Bu)(BBr2)2

reaction mixture in comparison to the amount of alkyl
bromide produced, could be achieved With the composition
of the present invention.

Binuclear boron bromides Were prepared in high yields by

combining

Salpen("Bu)[B(OMe)2]2

or

Salben(’Bu)

[B(OMe)2]2 With a stoichiometric amount of BBr3. To a

TABLE 1

stirring solution of Salpen(tBu)[B(OMe)2]2 (3.0 g, 4.62
mmol) in toluene (50 ml) Was added 1 M BBr3 in heptane

Percent dealkylation of phosphates With Sa1pen(‘Bu)(BBr7)7

(6.24 ml, 6.24 mmol). The reaction mixture Was stirred for
24 hours, and the solvent removed. The remaining solid Was
Washed With 10 ml of hexanes, and ?ltration and vacuum

drying yielded 3.28 g (88% yield) Salpen(tBu)(BBr2)2.
EXAMPLE 2

Preparation of Salben("Bu)(BBr2)2
20

To a stirring solution of Salben(tBu)[B(OMe)2]2 (1.0 g,
1.51 mmol) in toluene (50 ml) Was added 1 M BBr3 in
heptane (2.04 ml, 2.04 mmol). The reaction mixture Was

“The percent conversion Was determined by the amount of phosphate
remaining to the amount of alkyl bromide produced in the 1H NMR.

stirred for 18 hours at room temperature. The solution Was

concentrated to 10 ml, ?ltered, and dried. The yield Was 0.96

EXAMPLE 4

25

g (76% yield) Salben(’Bu)(BBr2)2.
NMR analysis shoWed a broad single peak (at 6 —0.57 and
—0.40 ppm, respectively) for both binuclear boron bromide
compounds prepared as described in Examples 1 and 2,
up?eld from a related chloride analogue Salpen("Bu)[BCl2]2

Dealkylation of Phosphates With Binuclear Boron

Compounds
30

Various binuclear boron compounds, synthesiZed substan
tially as described in Examples 1 and 2, Were evaluated for
dealkylation of phosphate esters as described in Example 3.

(at 6 6.21 ppm).
EXAMPLE 3
35

Dealkylation of Phosphates With Salpen(’Bu)

(BBr2)2
Salpen(tBu)(BBr2)2, prepared as described in Example 1,
Was evaluated for its ability to dealkylate various phosphate

40

esters. In a NMR tube, phosphate Was added to an equimolar

solution of Salpen(tBu)(BBr2)2 in CDCl3 and held at room
temperature for 30 minutes. The reaction Was monitored by

For comparison, a positive control consisting of BBr3 in
CDCl3 Was used. As shoWn in Tables 245, the compounds of
the present invention Were e?cective in cleaving phosphate
bonds for various phosphate compounds. In contrast, BBr3
Was ine?cective (Table 5). Activity of the boron halide
compounds of the present invention did not decrease With
extension of the alkyl chain on the phosphates. HoWever, a
slight decrease in activity of the compounds Was observed
With the branched phosphates such as (PhO)2((2-Et)HexO)

P(O).
TABLE 2

Dealkylation of phosphates by Salen ligands having the formula L[BBr2]2.

Phosphate
(PhO)2P(O)

30

24

30

24

30

24

30

24

30

24

30

24

L[BBr2]2

min.

hr.

min.

hr.

min.

hr.

min.

hr.

min.

hr.

min.

hr.

Sa1en(t)

76

94

26

32

42

57

61

77

48

58

88

89

Salpen(t)

74

82

68

74

99

99

84

99

75

83

98

98

Salben(t)

60

78

46

53

77

91

87

92

64

81

90

96

Salhen(t)

58

81

55

66

60

69

37

47

88

93

79

79
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TABLE 3
Dealkylation of phosphates by Salen ligands having the formula L[MePhBBr7]7.

Phosphate

(PhO)2P(O)
(MeO)1P(O)
L[MePhBBr]2
Salen(t)
Salpen(t)
Salben(t)
Salhen(t)

(EtO)1P(O)

(n—BuO)1P(O)

(MeO)7P(O)H (MeO)7P(O)Me (i—PrO)7P(O)H

(2-ethvlhexvl)

(MeSiO)1P(O)

30

24

30

24

30

24

30

24

30

24

30

24

30

24

30

24

min

hr.

min

hr.

min

hr.

min

hr.

min

hr.

min

hr.

min

hr.

min.

hr.

45
52
92
80

62
69
83
88

40
50
71
56

98
64
98
98

31
58
70
47

46
75
99
98

59
67
50
50

67
82
82
76

47
64
50
42

56
69
63
66

42
32
37
26

74
65
74
60

12
46
52
42

32
67
76
61

43
48
69
89

45
63
69
89

bond of a phosphate ester or ether, respectively, allowing a
nucleophilic attack by the halide at the ot-carbon. The

TABLE 4
I

I

I

reaction is depicted schematically in FIG. 5, using a phos

Dmlkylanon of Phosphms by Sal“ hgands havmg the

20 phate ester and a binuclear boron compound according to the
.
.
.
present 1nvent1on as an example. Accordingly, the present
invention contemplates use of such cationic intermediates

formula L[BCl7]7.

phosbhate

for dealkylation of phosphate esters and ethers as described
(MeO)1P(O)

(MeSiO)1P(O)

herein
25

L[BCl2]2

30 min.

24 hr.

30 min.

24 hr.

Salen(t)

7

45

84

87

Salpen(t)

20

66

75

Salben(t)

11

53

81

84

Salhen(t)

7

47

57

63

4;

62

73

86

gamma)

32

EXAMPLE 6

Cleavage Of MTBE
_

30

_

Methyl tertlary butyl ether Was added to a CDCl3 solut1on

of binuclear boron ligands synthesized substantially as
described in Examples 1 and 2 (4:1 ratio of MTBEzligand).
TABLE 5

Dealglation of phosphates by BBr3.
Phosphate

(PhO)2P(O)
(MeO)1P(O)

BBr3
B-Bromo

(EtO)1P(O)

(n—BuO)1P(O)

(MeO)7P(O)H (MeO)7P(O)Me (i—PrO)7P(O)H

(2-ethvlhexvl)

(MeSiO)1P(O)

30

24

30

24

30

24

30

24

30

24

30

24

30

24

30

24

min.

hr.

min.

hr.

min.

hr.

min

hr.

min

hr.

min

hr.

min

hr.

min.

hr.

1.1
74

3.4
99

0
37

2.7
66

5
31

0
54

1
84

12
87

2
58

2
92

0
76

0
84

0
87

7
95

11
99

20
99

aB-Bromocatecholborane

EXAMPLE 5

The solution Was held at room temperature, and the reaction
50

Catalytic Process for Dealkylating Phosphates
Because Salpen("Bu)(BBr2)2 can be generated in situ from
Salpen("Bu)[B(OMe)2]2 and BBr3, the process can be made
catalytic. The reaction is shoWn schematically in FIG. 4. In
a NMR tube, equimolar amounts of (MeO)3P(O) and BBr3
Were added to a solution of Salpen(’Bu)(BBr2)2 in CDCl3 in

55

TABLE 6

the ratio of 20:1 of phosphate to borate and held at room

temperature. The reaction Was monitored by 1H NMR.

monitored by 1H NMR. Percent dealkylation Was monitored
by comparing the amount of methyl bromide produced to the
amount of trimethyl phosphate remaining. As shoWn in
Table 6, the compositions of the present invention are
capable of dealkylating ethers as Well as phosphate esters.

Cleavage of MTBE by bimetallic boron halide ligand.
60

Dealkylation of trimethyl phosphate occurred Within ?ve
minutes. Dealkylation (75% conversion) occurred Within 30

Conversion (%)"‘

minutes at a substrate to catalyst ratio of 200:1.

Ligand

30 min.

24 hr.

12
3

39.3
10

While not Wishing to be bound by any theory, the mecha
nism may be one in Which a cationic intermediate, Which
may be depicted in one embodiment of this invention as
[(chelate)BBr]+, coordinates the PiO4C or C4O4C

65

Salen(‘Bu)[BBr2]2
Salpen(‘Bu)[BBr2]2

US 7,166,591 B1
9

10
3. The chemical compound of claim 1, Wherein Y is boron
or aluminum.

TABLE 6-continued

4. The chemical compound of claim 1, Wherein X is
chlorine, bromine, or iodine.
5. The chemical compound of claim 1, Wherein n is 2.

Cleavage of MTBE by bimetallic boron halide ligand.
Conversion % “

Ligand

Salben(‘Bu)[BBr2]2
SalhenCBu)[BBr2]2

30 min.

24 hr.

5
1

25
8

6. A composition comprising a chelating ligand L, the

ligand having the general formula:

3Percent dealkylation Was determined by comparing the amount of methyl
bromide produced to the amount of trimethyl phosphate remaining in the
1H NMR.

The foregoing description is presented for purposes of
illustration and description of the various aspects of the
invention. The descriptions are not intended to be exhaustive
or to limit the invention to the precise form disclosed. The
embodiments described above Were chosen to provide the

best illustration of the principles of the invention and its
practical application to thereby enable one of ordinary skill

20

in the art to utilize the invention in various embodiments and
With various modi?cations as are suited to the particular use

contemplated. All such modi?cations and variations are
Within the scope of the invention as determined by the

25

appended claims When interpreted in accordance With the
breadth to Which they are fairly, legally and equitably
entitled.
What is claimed is:

1. A chemical compound having a chelating ligand L of
the general formula:

30

Wherein Y is selected from the Group 13 elements con

sisting of boron, aluminum, gallium, indium, and tel
lurium, X is selected from the halide group consisting

tBu

of ?uorine, chlorine, bromine, iodine, and astatine, E
35

and E' are selected from the group consisting of C, N,
O, and S, and n is an integer having a value of at least
1.
7. A method for dealkylation of a phosphate ester or an

40

ether, comprising contacting the phosphate ester or ether
With the chemical compound of claim 1.
8. The method of claim 7, wherein:
L is selected from the group consisting of Salen (tBu),

Salpen (tBu), Salben (tBu), and Salhen (tBu);
Y is boron or aluminum;
45

X is chlorine, bromine, or iodine; and
n is 2.

50

9. A catalytic method for dealkylation of a phosphate ester
or an ether, comprising contacting the phosphate ester or
ether With the chemical compound of claim 1 in the presence

of BBr3.
10. The method of claim 9, Wherein:
L is selected from the group consisting of Salen (tBu),

Salpen (tBu), Salben (tBu), and Salhen (tBu);
Wherein Y is selected from the Group 13 elements con

55

sisting of boron, aluminum, gallium, indium, and tel

X is chlorine, bromine, or iodine; and

lurium, X is selected from the halide group consisting

n is 2.

of ?uorine, chlorine, bromine, iodine, and astatine, E
and E' are selected from the group consisting of C, N,
O, and S, and n is an integer having a value of at least
1.

2. The chemical compound of claim 1, Wherein L is

Y is boron or aluminum;

60

11. The method of claim 9, Wherein the phosphate ester or
ether and BBr3 are present in equimolar amounts.
12. The method of claim 9, Wherein the dealkylation is
conducted at ambient temperature.

selected from the group consisting of Salen (tBu), Salpen

(tBu), Salben (tBu), and Salhen (tBu).

*

*

*

*

*

